| scholarly article | Q13442814 |
| P2093 | author name string | Yi Wang | |
| Yang Xiao | |||
| Yan-Yan Wang | |||
| Wen-Ping Xu | |||
| Jing-Jing Guo | |||
| Lai-Lai Li | |||
| P2860 | cites work | Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients | Q24555072 |
| Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases | Q33685876 | ||
| Antiplatelet effects of qishen yiqi dropping pill in platelets aggregation in hyperlipidemic rabbits | Q36210649 | ||
| Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages | Q40378838 | ||
| Alleviation of iron induced oxidative stress by the grape fruit flavanone naringin in vitro | Q42749225 | ||
| Dose-effect relationship of traditional Chinese medicine formula for promoting blood circulation to remove stasis on ADP-induced platelet aggregation and rabbit plasma thrombin time | Q43139644 | ||
| Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). | Q43163855 | ||
| Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits | Q43807024 | ||
| Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress | Q44308552 | ||
| Protective effect of naringin, a bioflavonoid on glycerol-induced acute renal failure in rat kidney | Q45008879 | ||
| Variability of platelet aggregate dispersal with glycoprotein IIb-IIIa antagonists eptifibatide and abciximab. | Q45957006 | ||
| Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet-leukocyte aggregate formation occur simultaneously in hyperlipidemia? | Q46777263 | ||
| Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis | Q50324471 | ||
| Support for linkage of familial combined hyperlipidemia to chromosome 1q21-q23 in Chinese and German families | Q56982669 | ||
| Antiplatelet drugs | Q58481433 | ||
| THE AGGREGATION OF BLOOD PLATELETS | Q76530970 | ||
| P433 | issue | 3 | |
| P921 | main subject | hyperlipidemia | Q1079120 |
| platelet aggregation | Q14913634 | ||
| P304 | page(s) | 968-972 | |
| P577 | publication date | 2014-06-20 | |
| P1433 | published in | Experimental and Therapeutic Medicine | Q23979083 |
| P1476 | title | Naringin administration inhibits platelet aggregation and release by reducing blood cholesterol levels and the cytosolic free calcium concentration in hyperlipidemic rabbits | |
| P478 | volume | 8 |
| Q51519824 | Antiplatelet activity of flavonoid and coumarin drugs. |
| Q38603502 | Antiplatelet effect of active components derived from Chinese herbal medicine |
| Q46639895 | Naringenin ameliorates renal and platelet purinergic signalling alterations in high-cholesterol fed rats through the suppression of ROS and NF-κB signaling pathways. |
| Q57138556 | Naringin promotes cellular chemokine synthesis and potentiates mesenchymal stromal cell migration via the Ras signaling pathway |
| Q38606433 | The Protective Effect of Naringin against Bleomycin-Induced Pulmonary Fibrosis in Wistar Rats |
Search more.